Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Impax Laboratories Inc    IPXL   US45256B1017

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Impax Laboratories Inc : Impax Laboratories to Present at the UBS Global Healthcare Conference

05/20/2013 | 07:35am US/Eastern

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Healthcare Conference on Wednesday, May 22, at 9:00 a.m. Eastern Standard Time. The conference will be held at the Sheraton New York Hotel.

Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company's web site at This presentation will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at:

Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Investor Relations and Corporate Communications

© Business Wire 2013
Recommend :
React to this article
1d ago IMPAX LABORATORIES : IGI Laboratories Announces Second Quarter 2014 Results
07/15 IMPAX LABORATORIES : Other Events (form 8-K)
07/10 Polar Capital, Impax Asset Management Increase Assets Over Quarter
07/09 IMPAX LABORATORIES : Acquires Two Products from Actavis
07/09 IMPAX LABORATORIES : to Announce Results for Second Quarter 2014 on August 6
07/08 IMPAX LABORATORIES : Buys 2 Products from Actavis
07/07 IMPAX LABORATORIES : Eltel and Impax Asset Management sign a EUR 13 million wind..
07/07 IMPAX LABORATORIES : Kosher Certifications, Biologic License Applications, Posit..
07/02 IMPAX LABORATORIES : Labs Acquires Two Generic Products From Actavis
07/01 IMPAX LABORATORIES : to Announce Results for Second Quarter 2014 on August 6
Duration : Period :
Impax Laboratories Inc Technical Analysis Chart | IPXL | US45256B1017 | 4-Traders
Income Statement Evolution
Impax Laboratories Inc : Income Statement Evolution
More Financials
Dynamic quotes